Literature DB >> 17060585

Response of intrathecal baclofen resistance to dose reduction.

Joanna A Cooper1, Barbara Ridley.   

Abstract

Dose stabilization of intrathecal baclofen (ITB) is usually achieved within 6 to 18 months. In some patients, an increase in ITB dose may result in paradoxical unresponsiveness to baclofen. We present two cases demonstrating increased tone and functional decline with increasing ITB doses after a period of clinical stability. In both cases, reduction of ITB dose was associated with marked clinical improvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060585     DOI: 10.1212/01.wnl.0000240223.01418.2e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Use of intrathecal clonidine in patients with multiple sclerosis or spastic paraparesis.

Authors:  Joseph K Ho; Saud A Sadiq
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

Review 2.  Intrathecal baclofen for childhood hypertonia.

Authors:  A Leland Albright
Journal:  Childs Nerv Syst       Date:  2007-06-29       Impact factor: 1.475

3.  Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.

Authors:  Anke Stroet; Nadine Trampe; Andrew Chan
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.